K

Kotra Industries Bhd
KLSE:KOTRA

Watchlist Manager
Kotra Industries Bhd
KLSE:KOTRA
Watchlist
Price: 4.31 MYR
Market Cap: 639.2m MYR
Have any thoughts about
Kotra Industries Bhd?
Write Note

Relative Value

The Relative Value of one KOTRA stock under the Base Case scenario is 4.65 MYR. Compared to the current market price of 4.31 MYR, Kotra Industries Bhd is Undervalued by 7%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

KOTRA Relative Value
Base Case
4.65 MYR
Undervaluation 7%
Relative Value
Price
K
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
30
vs Industry
41
Median 3Y
2.9
Median 5Y
2.6
Industry
2.6
Forward
2.4
vs History
15
vs Industry
32
Median 3Y
11.5
Median 5Y
11.9
Industry
23
Forward
11.9
vs History
9
vs Industry
35
Median 3Y
9.7
Median 5Y
8.4
Industry
17.8
vs History
4
vs Industry
15
Median 3Y
18.4
Median 5Y
14.9
Industry
25.4
vs History
26
vs Industry
34
Median 3Y
2.5
Median 5Y
2.2
Industry
2.2
vs History
20
vs Industry
43
Median 3Y
2.6
Median 5Y
2.2
Industry
2.8
Forward
2.2
vs History
vs Industry
48
Median 3Y
0
Median 5Y
0
Industry
5.4
vs History
28
vs Industry
38
Median 3Y
8.1
Median 5Y
7.9
Industry
13.7
Forward
6.8
vs History
38
vs Industry
36
Median 3Y
10.1
Median 5Y
10.2
Industry
17.2
Forward
10.2
vs History
4
vs Industry
38
Median 3Y
8.6
Median 5Y
7.4
Industry
16.5
vs History
4
vs Industry
16
Median 3Y
13.4
Median 5Y
8.9
Industry
19.3
vs History
38
vs Industry
33
Median 3Y
2.6
Median 5Y
2.3
Industry
2

Multiples Across Competitors

KOTRA Competitors Multiples
Kotra Industries Bhd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
MY
Kotra Industries Bhd
KLSE:KOTRA
639.2m MYR 2.8 14.3 8.2 10.2
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
746.8B USD 18.3 89.2 48 53.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
365.6B USD 4.2 24.9 12 15.7
US
Merck & Co Inc
NYSE:MRK
249.1B USD 3.9 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
208.6B CHF 3.6 18.1 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.4B CHF 4.2 12.6 10 14.8
UK
AstraZeneca PLC
LSE:AZN
159.6B GBP 4.1 31.4 169.3 253.8
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
MY
K
Kotra Industries Bhd
KLSE:KOTRA
Average P/E: 30.8
14.3
34%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
89.2
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
24.9
-22%
US
Merck & Co Inc
NYSE:MRK
20.5
7 336%
CH
Roche Holding AG
SIX:ROG
18.1
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.4
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top